Literature DB >> 22721264

The Disability burden of COPD.

Julia Thornton Snider1, John A Romley, Ken S Wong, Jie Zhang, Michael Eber, Dana P Goldman.   

Abstract

Affecting an estimated 12.6 million people and causing over 100,000 deaths per year, chronic obstructive pulmonary disease (COPD) exacts a heavy burden on American society. Despite knowledge of the impact of COPD on morbidity, mortality, and health care costs, little is known about the association of the disease with economic outcomes such as employment and the collection of disability. We quantify the impact of COPD on Americans aged 51 and older-in particular, their employment prospects and their likelihood of collecting federal disability benefits-by conducting longitudinal regression analysis using the Health and Retirement Study. Controlling for initial health status and a variety of sociodemographic factors, we find that COPD is associated with a decrease in the likelihood of employment of 8.6 percentage points (OR = 0.58, 95% CI 0.50-0.67), from 44% to 35%. This association rivals that of stroke and is larger than those of heart disease, cancer, hypertension, and diabetes. Furthermore, COPD is associated with a 3.9 percentage point (OR 2.52, 95% CI 2.00-3.17) increase in the likelihood of collecting Social Security Disability Insurance (SSDI), from 3.2% to 7.1%, as well as a 1.7 percentage point (OR 2.87, 95% CI 2.02-4.08) increase in the likelihood of collecting Supplemental Security Income (SSI), from 1.0% to 2.7%. The associations of COPD with SSDI and SSI are the largest of any of the conditions studied. Our results are consistent with the hypothesis that COPD imposes a substantial burden on American society by inhibiting employment and creating disability.

Entities:  

Mesh:

Year:  2012        PMID: 22721264     DOI: 10.3109/15412555.2012.696159

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  24 in total

1.  Introduction to the special section: sustainability of work with chronic health conditions.

Authors:  William S Shaw; Torill H Tveito; Cécile R L Boot
Journal:  J Occup Rehabil       Date:  2013-06

Review 2.  Ageing and the epidemiology of multimorbidity.

Authors:  Miguel J Divo; Carlos H Martinez; David M Mannino
Journal:  Eur Respir J       Date:  2014-08-19       Impact factor: 16.671

Review 3.  The COPD Foundation: Celebrating a Decade of Progress and Looking Ahead to a Cure.

Authors:  Byron M Thomashow; John W Walsh; Elisha D F Malanga
Journal:  Chronic Obstr Pulm Dis       Date:  2014-05-06

4.  SERPINA1 Hepatocyte-Specific Promoter Polymorphism Associate with Chronic Obstructive Pulmonary Disease in a Study of Kashmiri Ancestry Individuals.

Authors:  Arif Bashir; Younis M Hazari; Samirul Bashir; Nazia Hilal; Mariam Banday; Mir Khurshid Iqbal; Tariq Rashid Jan; Syed Suraiya Farooq; Naveed Nazir Shah; Khalid Majid Fazili
Journal:  Lung       Date:  2018-05-26       Impact factor: 2.584

5.  Effect of hospital use of oral nutritional supplementation on length of stay, hospital cost, and 30-day readmissions among Medicare patients with COPD.

Authors:  Julia Thornton Snider; Anupam B Jena; Mark T Linthicum; Refaat A Hegazi; Jamie S Partridge; Chris LaVallee; Darius N Lakdawalla; Paul E Wischmeyer
Journal:  Chest       Date:  2015-06       Impact factor: 9.410

6.  Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes.

Authors:  Kevin Molloy; Craig P Hersh; Valerie B Morris; Tomás P Carroll; Catherine A O'Connor; Jessica A Lasky-Su; Catherine M Greene; Shane J O'Neill; Edwin K Silverman; Noel G McElvaney
Journal:  Am J Respir Crit Care Med       Date:  2014-02-15       Impact factor: 21.405

7.  Prevalence of Airflow Obstruction in U.S. Adults Aged 40-79 Years: NHANES Data 1988-1994 and 2007-2010.

Authors:  Brent Doney; Eva Hnizdo; Charles F Dillon; Ryne Paulose-Ram; Timothy Tilert; Michael Wolz; Lu-Ann Beeckman-Wagner
Journal:  COPD       Date:  2015-08       Impact factor: 2.409

8.  Prevalence of chronic obstructive pulmonary disease among US working adults aged 40 to 70 years. National Health Interview Survey data 2004 to 2011.

Authors:  Brent Doney; Eva Hnizdo; Girija Syamlal; Greg Kullman; Cecil Burchfiel; Christopher J Martin; Priscah Mujuru
Journal:  J Occup Environ Med       Date:  2014-10       Impact factor: 2.162

9.  Hospitalization increases while economic status deteriorates in late stages of chronic obstructive pulmonary disease: the Korean National Health and Nutrition Examination Survey for 2007-2015.

Authors:  Hyung Koo Kang; Jae-Woo Jung; Min-Jong Kang; Deog Kyeom Kim; Hayoung Choi; Young Jae Cho; Seung Hun Jang; Chang Hoon Lee; Yeon Mok Oh; Jisook Park; Jae Yeol Kim
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

10.  The clinical and economic burden of chronic obstructive pulmonary disease in the USA.

Authors:  Anthony J Guarascio; Shauntá M Ray; Christopher K Finch; Timothy H Self
Journal:  Clinicoecon Outcomes Res       Date:  2013-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.